The Evaluation of Quantitative MRA for Cerebral Amyloid Angiopathy with Vascular Risk Factors

定量磁共振血管造影在伴有血管危险因素的脑淀粉样血管病中的应用评价

阅读:1

Abstract

BACKGROUND AND PURPOSE: Cerebral amyloid angiopathy (CAA) is a leading cause of intracranial hemorrhage and cognitive decline in the elderly. This study seeks to investigate the quantitative MRA features as new markers of CAA. MATERIALS AND METHODS: In this cross-sectional study, consecutive patients with CAA and controls who underwent 3D time-of-flight MRA were included. Demographic and clinical data, including sex, age, diabetes, smoking, hypertension, and atrial fibrillation, were collected. Radiologic features, including the microhemorrhage classification, siderosis, and Fazekas scale, were also collected. Using in-house developed semiautomated software (VesselVoyager), quantitative MRA features, including total arterial length, number of branches, and tortuosity, were extracted. Univariable and multivariable logistic regression analyses were then performed to compare the CAA and non-CAA cohorts. RESULTS: Seventy-four patients were included: 43 with CAA and 31 controls. Quantitative MRA analysis showed that patients with CAA had significantly reduced total arterial length (1900 ± 1240 mm versus 2880 ± 1540 mm; P = .006). Univariable logistic regression identified total arterial length (P = .009), age (P = .012), and total branch number (P = .107) as relevant predictors of CAA. In multivariable analysis, total arterial length (OR: 0.95; 95% CI: 0.92-0.99; P = .014) and age (OR: 1.06; 95% CI: 1.01-1.12; P = .023) remained independently associated with CAA diagnosis. CONCLUSIONS: Quantitative MRA total arterial length is inversely, independently, and significantly associated with CAA diagnosis. This could potentially serve as an imaging marker of CAA diagnosis and potentially further elucidate vascular segment involvement in patients with CAA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。